Cargando…
Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608423/ https://www.ncbi.nlm.nih.gov/pubmed/34823009 http://dx.doi.org/10.1016/j.cmi.2021.11.017 |
_version_ | 1784602744436293632 |
---|---|
author | Fally, Markus Mathioudakis, Alexander G. Wingfield Digby, James Williamson, Paula R. |
author_facet | Fally, Markus Mathioudakis, Alexander G. Wingfield Digby, James Williamson, Paula R. |
author_sort | Fally, Markus |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8608423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86084232021-11-23 Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted? Fally, Markus Mathioudakis, Alexander G. Wingfield Digby, James Williamson, Paula R. Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-03 2021-11-23 /pmc/articles/PMC8608423/ /pubmed/34823009 http://dx.doi.org/10.1016/j.cmi.2021.11.017 Text en © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Fally, Markus Mathioudakis, Alexander G. Wingfield Digby, James Williamson, Paula R. Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted? |
title | Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted? |
title_full | Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted? |
title_fullStr | Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted? |
title_full_unstemmed | Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted? |
title_short | Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted? |
title_sort | outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with covid-19: is the meta core outcome set (meta-cos) adopted? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608423/ https://www.ncbi.nlm.nih.gov/pubmed/34823009 http://dx.doi.org/10.1016/j.cmi.2021.11.017 |
work_keys_str_mv | AT fallymarkus outcomesassessedintherapeuticrandomizedcontrolledtrialsinhospitalizedpatientswithcovid19isthemetacoreoutcomesetmetacosadopted AT mathioudakisalexanderg outcomesassessedintherapeuticrandomizedcontrolledtrialsinhospitalizedpatientswithcovid19isthemetacoreoutcomesetmetacosadopted AT wingfielddigbyjames outcomesassessedintherapeuticrandomizedcontrolledtrialsinhospitalizedpatientswithcovid19isthemetacoreoutcomesetmetacosadopted AT williamsonpaular outcomesassessedintherapeuticrandomizedcontrolledtrialsinhospitalizedpatientswithcovid19isthemetacoreoutcomesetmetacosadopted |